Zealand Pharma A/S (ZLDPF)
43.00
-3.38
(-7.28%)
USD |
OTCM |
Sep 14, 16:00
Zealand Pharma Price : 43.00 for Sept. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 14, 2026 | 44.20 | 44.20 | 43.00 | 43.00 | 1288.00 |
| Sep 11, 2026 | 46.38 | 46.38 | 46.38 | 46.38 | 41.00 |
| Sep 10, 2026 | 46.38 | 46.38 | 46.38 | 46.38 | 105.00 |
| Sep 09, 2026 | 46.38 | 46.38 | 46.38 | 46.38 | 12.00 |
| Sep 08, 2026 | 46.61 | 46.77 | 46.04 | 46.38 | 8757.00 |
| Sep 04, 2026 | 47.64 | 47.64 | 47.64 | 47.64 | 50.00 |
| Sep 03, 2026 | 47.73 | 47.73 | 47.64 | 47.64 | 2035.00 |
| Sep 02, 2026 | 47.30 | 47.30 | 47.30 | 47.30 | 60.00 |
| Sep 01, 2026 | 47.30 | 47.30 | 47.30 | 47.30 | 400.00 |
| Aug 31, 2026 | 47.00 | 47.00 | 46.30 | 46.58 | 818.00 |
| Aug 28, 2026 | 49.28 | 49.28 | 49.28 | 49.28 | 2.000 |
| Aug 27, 2026 | 49.28 | 49.28 | 49.28 | 49.28 | 352.00 |
| Aug 26, 2026 | 51.80 | 51.80 | 51.80 | 51.80 | 0.000 |
| Aug 25, 2026 | 51.70 | 51.80 | 51.70 | 51.80 | 302.00 |
| Aug 24, 2026 | 48.24 | 48.24 | 48.24 | 48.24 | 439.00 |
| Aug 21, 2026 | 50.00 | 51.22 | 50.00 | 50.51 | 5255.00 |
| Aug 20, 2026 | 50.00 | 50.00 | 50.00 | 50.00 | 0.000 |
| Aug 19, 2026 | 50.00 | 50.00 | 50.00 | 50.00 | 1013.00 |
| Aug 18, 2026 | 49.07 | 49.07 | 49.07 | 49.07 | 3.000 |
| Aug 17, 2026 | 49.07 | 49.07 | 49.07 | 49.07 | 100.00 |
| Aug 14, 2026 | 52.68 | 52.68 | 52.68 | 52.68 | 11.00 |
| Aug 13, 2026 | 52.68 | 52.68 | 52.68 | 52.68 | 180.00 |
| Aug 12, 2026 | 51.80 | 51.80 | 51.80 | 51.80 | 78.00 |
| Aug 11, 2026 | 51.80 | 51.80 | 51.80 | 51.80 | 147.00 |
| Aug 10, 2026 | 50.50 | 50.50 | 50.50 | 50.50 | 12.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Genmab A/S | 34.15 |
| Ascendis Pharma A/S | 239.88 |
| Bavarian Nordic A/S | 10.44 |
| Evaxion AS | 3.05 |
| ACADIA Pharmaceuticals, Inc. | 26.77 |
Price Related Metrics
| PE Ratio | 7.168 |
| PS Ratio | 4.20 |
| Price to Book Value | 1.090 |
| Earnings Yield | 13.95% |
| Market Cap | 3.002B |
| Operating PE Ratio | 8.333 |
| Normalized PE Ratio | 7.111 |